[go: up one dir, main page]

WO1992005278A3 - Procede de determination de l'expression differentielle de arn pour la proteine precurseur de l'amyloide - Google Patents

Procede de determination de l'expression differentielle de arn pour la proteine precurseur de l'amyloide Download PDF

Info

Publication number
WO1992005278A3
WO1992005278A3 PCT/EP1991/001772 EP9101772W WO9205278A3 WO 1992005278 A3 WO1992005278 A3 WO 1992005278A3 EP 9101772 W EP9101772 W EP 9101772W WO 9205278 A3 WO9205278 A3 WO 9205278A3
Authority
WO
WIPO (PCT)
Prior art keywords
app
precursor protein
mrna
amyloid precursor
determination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1991/001772
Other languages
English (en)
Other versions
WO1992005278A2 (fr
Inventor
Valle Francesco Della
Antonio Morandi
Alessandro Negro
Lanfranco Callegaro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia SpA filed Critical Fidia SpA
Publication of WO1992005278A2 publication Critical patent/WO1992005278A2/fr
Publication of WO1992005278A3 publication Critical patent/WO1992005278A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention se rapporte à un procédé de détermination qualitative et quantitative de l'expression des différents ARNs messagers pour la protéine humaine précurseur de l'amyloïde (APP) dans les tissus biologiques humains, cette méthodologie pouvant être utilisée pour effectuer un contrôle diagnostique de la maladie d'Alzheimer.
PCT/EP1991/001772 1990-09-17 1991-09-17 Procede de determination de l'expression differentielle de arn pour la proteine precurseur de l'amyloide Ceased WO1992005278A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT04169190A IT1243515B (it) 1990-09-17 1990-09-17 Metodo per la determinazione della espressione differenziale degli rna messangers per la proteina precursore dell'amiloide (amyloid precursor protein, app)
IT41691A/90 1990-09-17

Publications (2)

Publication Number Publication Date
WO1992005278A2 WO1992005278A2 (fr) 1992-04-02
WO1992005278A3 true WO1992005278A3 (fr) 1992-05-14

Family

ID=11253064

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1991/001772 Ceased WO1992005278A2 (fr) 1990-09-17 1991-09-17 Procede de determination de l'expression differentielle de arn pour la proteine precurseur de l'amyloide

Country Status (4)

Country Link
CN (1) CN1062925A (fr)
AU (1) AU8492591A (fr)
IT (1) IT1243515B (fr)
WO (1) WO1992005278A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
NZ242955A (en) * 1991-06-13 1995-01-27 Ici Plc Dna containing gene sequences corresponding to sequences causing alzheimers disease, detection, recombinant yeast with such code
CA2129787A1 (fr) * 1993-08-27 1995-02-28 Russell G. Higuchi Surveillance de plusieurs reactions d'amplification simultanement et analyse de ces reactions simultanement
CN103884698B (zh) 2004-06-07 2017-04-12 先锋生物科技股份有限公司 用于微流体器件的光学透镜系统和方法
US7874026B2 (en) 2007-08-24 2011-01-25 Double Space Bed Systems, Inc. System and method for raising and lowering a bed
CN105717182B (zh) * 2016-03-10 2018-05-11 中南大学 一种用于同步检测淀粉样多肽单体和聚集体的生物传感器及其构建方法和应用

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Biochemical and Biophysical Research Communications, vol. 157, no. 2, 15 December 1988, S. TANAKA et al.: "Three types anyloid protein precursor mRNA in human brain: their differential expression in Alzheimer's disease", pages 472-479, see whole article *
Biochemical and Biophysical Research Communications, vol. 166, no. 3, 14 February 1990, J. KANG et al.: "Differential splicing of Alzheimer's disease amyloid A4 precursor RNA in rat tissues: PreA4695 mRNA is predominantly produced in rat and human brain", pages 1192-1200, see whole article *
Biochemical and Biophysical Research Communications, vol. 171, no. 1, 31 August 1990, K. YOSHIKAWA et al.: "Neural differentiation increases expression of Alzheimer amyloid protein precursor gene in murine embryonal carcinoma cells", pages 204-209, see whole article *
Cellular and Molecular Neurobiology, vol. 10, no. 4, December 1990, R.J. DONNELLY et al.: "Interleukin-1 stimulates the beta-amyloid precursor protein promoter", pages 485-496, see summary *
FEBS Letters, vol. 241, no. 1,2, December 1988, L. AUTILIO-GAMBETTI et al.: "The amyloid precursor protein of Alzheimer disease is expressed as a 130 kDa polypeptide in various cultured cell types", pages 94-98, see whole article *
Proceedings of the National Academy of Science of USA, vol. 86, October 1989, D. GOLDGABER et al.: "Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells", pages 7606-7610, see whole article (cited in the application) *
Proceedings of the National Academy of Sciences of USA, vol. 88, January 1991, M.J. ADLER et al.: "Increased gene expression of Alzheimer disease beta-amyloid precursor protein in senescent cultured fibroblasts", pages 16-20, see whole article *
Science, vol. 241, no. 4869, 26 August 1988, M.R. PALMERT et al.: "Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease", pages 1080-1804, see whole article *

Also Published As

Publication number Publication date
IT1243515B (it) 1994-06-16
IT9041691A1 (it) 1992-03-17
CN1062925A (zh) 1992-07-22
IT9041691A0 (it) 1990-09-17
WO1992005278A2 (fr) 1992-04-02
AU8492591A (en) 1992-04-15

Similar Documents

Publication Publication Date Title
AU5292290A (en) Diagnostic method for alzheimer's disease: examination of non-neural tissue
WO1998027226A3 (fr) Procede d'etablissement d'un pronostic pour un patient atteint d'une maladie neurologique
WO1995005604A3 (fr) Procedes de diagnostic de la maladie d'alzheimer
WO2001036972A3 (fr) Elisa pour facteur de croissance endotheliale
DE69631738D1 (de) Medizinische implantierbare Vorrichtung für elektrochemische Messungen von Bluteigenschaften
DE69635174D1 (de) Nichtinvasive Vorrichtung zur Blutuntersuchung
ZA95755B (en) Procedure for verifying the accuracy of non-invasive blood glucose measurement instruments
IL88691A (en) Method and device for noninvasive acoustic testing of elasticity of soft biological tissues
AU2256192A (en) A non-invasive method and apparatus for measuring concentration of analytes in living tissue
AU1364292A (en) Non-invasive device and method for determining concentrations of various components of blood or tissue
ATE223051T1 (de) Verfahren zur diagnose gutartiger prostataerkrankungen
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
WO2002041842A3 (fr) Anticorps pti-hs7 destine au traitement de la maladie d'alzheimer et d'autres amyloidoses et de la maladie de parkinson
AU7260496A (en) A method and diagnostic test kit for use in aiding the diagnosis of fibromyyalgia and chronic fatigue syndrome (CFS)
CA2264757A1 (fr) Procede de diagnostic de l'atherosclerose
AU2667197A (en) Stabilized preparations of human troponins and modifications thereof, diagnostic assay methods and assay kits
CA2264754A1 (fr) Procede de diagnostic de l'atherosclerose
WO1992005278A3 (fr) Procede de determination de l'expression differentielle de arn pour la proteine precurseur de l'amyloide
AU5153398A (en) Diagnostic method for the detection of alzheimer's disease in living patients
EP0873421A4 (fr) METHODE DIAGNOSTIQUE ET TROUSSE ASSOCIEE DE DETERMINATION DU GENOTYPE Rh DE GROUPES SANGUINS
ES8501630A1 (es) Un metodo para detectar o vigilar el estado de una condicion patologica humana que implica proteina de tejido conjuntivo.
AU6010494A (en) Method of assaying human tau protein, kit therefor, and diagnostic method
AU6186594A (en) Method for non-invasive measurement of concentration of analytes in blood
RU96121426A (ru) Способ диагностики опийной наркомании
RU95121019A (ru) Способ определения степени магниточувствительности человека

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA FI HU JP KR NO SU US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA FI HU JP KR NO SU US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA